• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1600036 重组人鼠嵌合抗CD20单克隆抗体注射液 rituximab Injection Biological Products(2) New Drug Application 2016-08-03 浙江特瑞思药业股份有限公司 Zhejiang Teruisi Pharmaceutical Inc Certificate Issued 2017-07-21 view
CXSL1600130 重组人源化抗VEGF单克隆抗体注射液 Injection Biological Products(2) New Drug Application 2017-03-02 浙江特瑞思药业股份有限公司 Zhejiang Teruisi Pharmaceutical Inc Certificate Issued 2017-11-21 view
CXSL1700031 注射用TRS005 TRS-005 Lyophilized Biological Products(1) New Drug Application 2017-07-06 浙江特瑞思药业股份有限公司 Zhejiang Teruisi Pharmaceutical Inc Certificate Issued 2018-06-08 view